Evidence mapPaperPMID 40623552Full record

ArticleEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists2025

Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone β.

Timothy M E Davis, Wendy A Davis, Carla Moran, Greta Lyons, Ellis Bryden, Krishna Chatterjee

Abstract read
In one paragraph

Article in Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Timothy M E DavisUniversity of Western Australia, Medical School, Fremantle Hospital, Fremantle, Western Australia, Australia; Department of Endocrinology and Diabetes, Fiona Stanley and Fremantle Hospitals, Murdoch, Western Australia, Australia. Electronic address: tim.davis@uwa.edu.au.
Wendy A DavisUniversity of Western Australia, Medical School, Fremantle Hospital, Fremantle, Western Australia, Australia.
Carla MoranDepartment of Endocrinology, Beacon Hospital, Dublin, Ireland; Department of Endocrinology and Diabetes Mellitus, St. Vincent's University Hospital, Dublin, Ireland; School of Medicine, University College, Dublin, Ireland.
Greta LyonsInstitute of Metabolic Science, University of Cambridge, Cambridge, UK.
Ellis BrydenDepartment of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge, UK.
Krishna ChatterjeeInstitute of Metabolic Science, University of Cambridge, Cambridge, UK. Electronic address: kkc1@medschl.cam.ac.uk.

Funding

Department of Health NIHR203312Wellcome Trust 210755
6 · The paper itself

Abstract

objectiveTo assess determinants of dyslipidemia (specifically raised serum low-density lipoprotein cholesterol and triglycerides, and reduced high-density lipoprotein cholesterol) in individuals with Resistance to Thyroid Hormone β (RTHβ).

methodsMultivariable linear regression analyses of cross-sectional fasting serum lipid profiles from 105 genetically-confirmed individuals with RTHβ (mean age 40.0 years, 40% males) were conducted, including candidate variables with plausible independent associations with the individual components of dyslipidemia such as indices of thyroid function, plasma non-esterified fatty acid concentrations, and insulin resistance assessed using the Homoeostasis Model Assessment equation.

resultsAge was positively related to both serum total and low-density lipoprotein-cholesterol concentrations (P < .001), while there were similar directional associations between body mass index and total:high-density lipoprotein-cholesterol ratio, and Homoeostasis Model Assessment-insulin resistance and serum triglycerides (P ≤ .007). Plasma non-esterified fatty acid concentrations were not associated with serum triglycerides. The only thyroid function measure revealed by the individual models was an inverse association between reverse triiodothyronine and serum triglycerides (P = .009).

conclusionsThe dyslipidemia associated with RTHβ shares recognized contributory factors found in studies of the general population but appears independent of thyroid status. The reason for the significant inverse association between circulating reverse triiodothyronine and serum triglyceride concentrations is unclear and merits further investigation.

Indexed as

DyslipidemiasThyroid Hormone Resistance SyndromeAdultCholesterol, HDLCholesterol, LDLCross-Sectional StudiesFemaleHumansInsulin ResistanceMaleMiddle AgedTriglyceridesCholesterol, HDLCholesterol, LDLTriglyceridesdyslipidemiainsulin resistanceResistance to Thyroid Hormone β

Identifiers

PMID40623552
PMCPMC7618671

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.